The latest news and breakthrough developments from the field of cancer research. We bring you the latest updates from organisations looking into diagnosing and treating all types of cancers using the latest scientific advancements and what is being done to improve patient care.
A groundbreaking study from the Paul Scherrer Institute (PSI) in collaboration with Inselspital–Bern University Hospital has unveiled a promising new therapy for lymphoma using the radioactive isotope terbium-161.
A new visualisation tool is shedding light on breast cancer spread. This innovative fluorescent probe, called Illusia, allows researchers to observe dynamic signalling within moving cancer cells, potentially opening new avenues for treatment and preventing metastatic spread.
The National Institute for Health and Care Research Great Ormond Street Hospital Biomedical Research Centre is developing a new virtual reality (VR) game to help children rehabilitate after brain tumour treatment.
World Cancer Research Fund International (WCRFI) is a not-for-profit organisation that leads a network of cancer prevention charities, including the American Institute for Cancer Research, World Cancer Research Fund in the UK, Wereld Kanker Onderzoek Fonds in the Netherlands and World Cancer Research Fund Hong Kong. They are dedicated to funding research on cancer, specifically how diet, weight, and physical activity affect cancer risk and survival.
The biotech company Roche is receiving support towards its efforts to advance cancer diagnosis, as the U.S. Food and Drug Administration (FDA) granted Breakthrough Device Designation to its new artificial intelligence-powered companion diagnostic device, the VENTANA® TROP2 (EPR20043) RxDx.
Patients are set to benefit from advanced technology that significantly enhances bowel cancer diagnosis, potentially reducing the need for invasive procedures.
Researchers from the University of Cambridge and the NIHR Cambridge Biomedical Research Centre have created an algorithm that finds vulnerable cancer tumours.
Research institutes have committed £5.5 million in funding for a world-leading research team tasked with making personalised medicines for bowel cancer patients.
